U.S. Markets open in 10 mins
  • S&P Futures

    3,650.25
    -10.25 (-0.28%)
     
  • Dow Futures

    29,684.00
    -120.00 (-0.40%)
     
  • Nasdaq Futures

    12,395.50
    -56.75 (-0.46%)
     
  • Russell 2000 Futures

    1,827.30
    -8.20 (-0.45%)
     
  • Crude Oil

    44.52
    -0.03 (-0.07%)
     
  • Gold

    1,821.20
    +2.30 (+0.13%)
     
  • Silver

    23.81
    -0.28 (-1.16%)
     
  • EUR/USD

    1.2071
    -0.0007 (-0.0604%)
     
  • 10-Yr Bond

    0.9390
    +0.0050 (+0.54%)
     
  • Vix

    21.09
    +0.52 (+2.53%)
     
  • GBP/USD

    1.3310
    -0.0113 (-0.8412%)
     
  • USD/JPY

    104.5000
    +0.1840 (+0.1764%)
     
  • BTC-USD

    19,132.33
    +138.43 (+0.73%)
     
  • CMC Crypto 200

    375.31
    -4.55 (-1.20%)
     
  • FTSE 100

    6,419.02
    +34.29 (+0.54%)
     
  • Nikkei 225

    26,800.98
    +13.44 (+0.05%)
     

Invitae: 3Q Earnings Snapshot

·1 min read

SAN FRANCISCO (AP) _ Invitae Corp. (NVTA) on Thursday reported a loss of $102.9 million in its third quarter.

On a per-share basis, the San Francisco-based company said it had a loss of 78 cents. Losses, adjusted for one-time gains and costs, were 62 cents per share.

The results fell short of Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 60 cents per share.

The genetic testing company posted revenue of $68.7 million in the period, which topped Street forecasts. Four analysts surveyed by Zacks expected $60 million.

Invitae shares have nearly tripled since the beginning of the year. In the final minutes of trading on Thursday, shares hit $45.91, nearly tripling in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NVTA at https://www.zacks.com/ap/NVTA